4//SEC Filing
DAMICO JENNIFER B. 4
Accession 0001225208-25-002412
CIK 0000078003other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:38 PM ET
Size
12.0 KB
Accession
0001225208-25-002412
Insider Transaction Report
Form 4
PFIZER INCPFE
DAMICO JENNIFER B.
SVP & Controller
Transactions
- Tax Payment
Common Stock
2025-02-23$26.30/sh−390$10,257→ 9,024 total - Exercise/Conversion
Common Stock
2025-02-22$30.17/sh+8,741$263,716→ 17,602 total - Tax Payment
Common Stock
2025-02-22$26.30/sh−390$10,257→ 17,212 total - Tax Payment
Common Stock
2025-02-22$26.08/sh−7,798$203,372→ 9,414 total - Exercise/Conversion
Stock Appreciation Rights
2025-02-22−8,741→ 0 totalExercise: $30.17From: 2025-02-22Exp: 2025-02-22→ Common Stock (8,741 underlying)
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 21, 2025.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001805617
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 7:38 PM ET
- Size
- 12.0 KB